Johnson & Johnson Initiates Patient Enrollment In Its SKYWARD Investigational Device Exemption Clinical Program

Benzinga Newsdesk www.benzinga.com Neutral 87.0%

Neg 0% Neu 87% Pos 0%

https://www.jnj.com/media-center/press-releases/johnson-johnson-begins-enrollment-in-pivotal-studies-evaluating-first-of-its-kind-carotid-ivl-platform